Clinical Trials Browser

Phase 2 × Stomach Neoplasms × pyrotinib × Clear all

NCT05111444 2021-11-08

Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms